ERGONOVINE MALEATE INJECTION USP DIN 02441241
Health Canada record
| Active ingredient(s) | ERGONOVINE MALEATE 0.25 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G02AB03 ERGOMETRINE |
| Original market date | 19-Feb-2016 |
| Current status date | 29-Jun-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ERGONOVINE MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01996096 | ERGONOVINE MALEATE INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | ERGONOVINE MALEATE 0.25 MG | Cancelled Pre Market |
| 02296144 | ERGONOVINE MALEATE INJECTION USP, 0.25MG/ML | ALVEDA PHARMACEUTICALS INC | Solution | ERGONOVINE MALEATE 0.25 MG | Cancelled (Unreturned Annual) |
International API supply for ERGONOVINE MALEATE
3 active FDA Drug Master Files.
Request a quote for ERGONOVINE MALEATE INJECTION USP